Brain Injuries, Acute
Conditions
Keywords
brain damage, sonography
Brief summary
The study will enable the clinical applicability of the multiple-spectral-sonography for detection of severe brain injury in ICU patients. For this, the ACG diagnostic system (Sonovum AG, Leipzig, Germany) should be used as additional diagnostic tool in prospective single-center study.
Detailed description
A multiple-step procedure, including repetition of the clinical examinations after a waiting period and use of additional technical diagnostic tools e.g. magnetic resonance tomography and Transcranial Doppler sonography (TCD) are needed for determining of severe brain injury and irreversible brain function failure. This study will enable the clinical applicability of the multiple-spectral-sonography for detection of severe brain injury in ICU patients. For this, the ACG diagnostic system (Sonovum AG, Leipzig, Germany) should be used as additional diagnostic tool in prospective single-center study. The ACG-method is a bedside non-invasive sonography that has been shown to be useful in previous studies analyzing circulatory changes in rat cerebral blood vessels, for example, to distinguish between brain-ischemia and -hemorrhage. Additionally, in the case of brain death, the spontaneous electrical activity, which can be measured by means of ACG as global elasticity, was not longer detectable. In the study should include 30 adult ICU-patients in patients suspect to severe brain injury. The inclusion of patients will be started if written informed consent was obtained from participants or their representatives. After the inclusion, the ACG is measured three times a day. In addition, the routinely practice (treatment and diagnostic) for patients with severe brain injury (neurological clinical examinations, use of additional technical diagnostic tools e.g. magnetic resonance tomography and Transcranial Doppler sonography (TCD); Standard Medical Care) should be made and documented. From all patients basic demographic data, pre-morbidity, vital parameters, blood parameters, Illness severity scores (APACHE-II, SOFA, GCS), drug levels, microbiological results and cranial MRI/CT results will be recorded.
Interventions
After inclusion three times at day measurements with ACG for each 45 minutes; a (non-invasive) sonography. The measurements will be stopped after final evaluation of the neurological status using common methods like magnetic resonance tomography, transcranial doppler sonography, electroencephalography and other methods.
Sponsors
Study design
Eligibility
Inclusion criteria
* suspected severe brain injury
Exclusion criteria
* open skull brain trauma * skull fractures in the temporal area * decompression-craniotomy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| acustocerebrography (ACG) | after inclusion: time-point 0 hours | changes in the ACG during the course of disease (especially the dimensionality of the time to flight of the ultrasound signal) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| SOFA | every day, at least after 28 days | Evaluation of the SOFA-Score |
| acustocerebrography (ACG) | Every day to 3 time-points. The measurements will be stopped after final evaluation of the neurological status, at least after 28 days | changes in the ACG during the course of disease (especially the dimensionality of the time to flight of the ultrasound signal) |
Countries
Germany